241 related articles for article (PubMed ID: 8808687)
21. The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes.
Sadoshima J; Izumo S
EMBO J; 1996 Feb; 15(4):775-87. PubMed ID: 8631299
[TBL] [Abstract][Full Text] [Related]
22. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
[TBL] [Abstract][Full Text] [Related]
23. Carbachol activates ERK2 in isolated gastric parietal cells via multiple signaling pathways.
Takeuchi Y; Pausawasdi N; Todisco A
Am J Physiol; 1999 Jun; 276(6):G1484-92. PubMed ID: 10362652
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
25. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation.
Lankester AC; van Schijndel GM; Rood PM; Verhoeven AJ; van Lier RA
Eur J Immunol; 1994 Nov; 24(11):2818-25. PubMed ID: 7525306
[TBL] [Abstract][Full Text] [Related]
26. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines.
Durstin M; Inhorn RC; Griffin JD
J Immunol; 1996 Jul; 157(2):534-40. PubMed ID: 8752899
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit.
Lanfrancone L; Pelicci G; Brizzi MF; Aronica MG; Casciari C; Giuli S; Pegoraro L; Pawson T; Pelicci PG; Arouica MG
Oncogene; 1995 Mar; 10(5):907-17. PubMed ID: 7898932
[TBL] [Abstract][Full Text] [Related]
29. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions.
Tridandapani S; Chacko GW; Van Brocklyn JR; Coggeshall KM
J Immunol; 1997 Feb; 158(3):1125-32. PubMed ID: 9013951
[TBL] [Abstract][Full Text] [Related]
30. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway.
van Biesen T; Hawes BE; Luttrell DK; Krueger KM; Touhara K; Porfiri E; Sakaue M; Luttrell LM; Lefkowitz RJ
Nature; 1995 Aug; 376(6543):781-4. PubMed ID: 7651538
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
33. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
34. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
[TBL] [Abstract][Full Text] [Related]
35. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
[TBL] [Abstract][Full Text] [Related]
37. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
38. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
[TBL] [Abstract][Full Text] [Related]
39. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation.
Welham MJ; Duronio V; Leslie KB; Bowtell D; Schrader JW
J Biol Chem; 1994 Aug; 269(33):21165-76. PubMed ID: 8063737
[TBL] [Abstract][Full Text] [Related]
40. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets.
Miyakawa Y; Oda A; Druker BJ; Kato T; Miyazaki H; Handa M; Ikeda Y
Blood; 1995 Jul; 86(1):23-7. PubMed ID: 7795229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
